Cargando…
Angiosarcomaafteradjuvantradiotherapy in high-risksquamouscell carcinoma of the vulva: a case report
Squamous cell carcinoma of the vulva represents 3-5% of gynecological cancers. The incidence is higher in postmenopausal patients; the mean age of women with vulvar cancer is between 64 and 70 years. Radiotherapy plays an increasing role in the treatment of high-risk squamous cell carcinoma of the v...
Autores principales: | Laliscia, Concetta, Gadducci, Angiolo, Pollina, Luca Emanuele, Paiar, Fabiola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045357/ https://www.ncbi.nlm.nih.gov/pubmed/32132888 http://dx.doi.org/10.5114/pm.2019.93114 |
Ejemplares similares
-
Vismodegibfor the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
por: Laliscia, Concetta, et al.
Publicado: (2019) -
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
por: Laliscia, Concetta, et al.
Publicado: (2016) -
Photon-based high-dose single-fraction radiosurgery, an effective treatment modality for recurrent uveal melanoma
por: Laliscia, Concetta, et al.
Publicado: (2023) -
Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy
por: Laliscia, Concetta, et al.
Publicado: (2021) -
High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience
por: Laliscia, Concetta, et al.
Publicado: (2021)